Clinico-epidemiological profile and disease severity of chronic obstructive pulmonary disease among patients in a primary care centre at central Kerala
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20231695Keywords:
Airflow limitation, Chronic respiratory disease, COPD, GOLD, Pulmonary function, SpirometryAbstract
Background: Chronic obstructive pulmonary disease (COPD) is a chronic disease usually caused by significant exposure to noxious particles and are not fully reversible. COPD represents an important public health challenge that is both preventable and treatable. The aim of this study was to describe the clinico-epidemiological profile of COPD patients and to assess the disease severity using spirometry among respiratory symptomatic in a primary care centre.
Methods: A cross sectional study was conducted among the COPD patients attending monthly pulmonology clinic in Urban Health centre, Ettumanoor, Kottayam from June to August 2019. The study comprised of 120 patients with symptoms suggestive of COPD attending the monthly respiratory clinic. Severity of airflow limitation assessed using spirometry results based on GOLD criteria. Clinical and epidemiological data were collected using a semi structured interview schedule.
Results: The mean age of the participants were 64±12 and 51.7% were males. The median duration of COPD symptoms for the study participants was 10 (IQR 11) years and 62.5% were having productive cough with dyspnoea as the major symptom. All males except two were smokers and the mean packyears were 42±4 years. As per GOLD guidelines 44 (36.7%) had severe disease, 11 (9.2%) had mild, 39 (32.5%) had moderate and 26 (21.7%) had very severe disease. The average forced expiratory volume in one second (FEV1) in study subjects was 54.8±7.5.
Conclusions: In view of the emerging public health risk, COPD need to be diagnosed and managed at the earliest to slow down the progression.
Metrics
References
Chronic obstructive pulmonary disease (COPD) Available at: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed on 7th November 2022.
Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis. 2014;9:289-300.
Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):121S-126S.
Jarhyan P, Hutchinson A, Khaw D, Prabhakaran D, Mohan S. Prevalence of chronic obstructive pulmonary disease and chronic bronchitis in eight countries: a systematic review and meta-analysis. Bull World Health Organ. 2022;100(3):216-30.
Soriano JB, Maier WC, Egger P, Visick G, Thakrar B, Sykes J, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax. 2000;55(9):789-94.
Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med. 2004;25(2):331-41.
2022 GOLD Reports. Global Initiative for Chronic Obstructive Lung Disease - GOLD. Available at: https://goldcopd.org/2022-gold-reports-2/. Accessed on 7th November 2022.
Spirometry Quick Guide. Global Initiative for Chronic Obstructive Lung Disease - GOLD. Available at: https://goldcopd.org/spirometry-quick-guide/. Accessed on 10th February 2023.
GOLD-2020-POCKET-GUIDE-ver1.0_FINAL-WMV.pdf. Available at: https://goldcopd.org/wp-content/uploads/2020/03/GOLD-2020-POCKET-GUIDE-ver1.0_FINAL-WMV.pdf. Accessed on 7th November 2022.
Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402-7.
Soriano JB, Ancochea J, Miravitlles M, García-Río F, Duran-Tauleria E, Muñoz L, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. European Respiratory Journal. 2010;36(4):758-65.
Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123(5):1684-92.
Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12):1043-7.
Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856-61.
Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1791-7.
Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006;173(1):79-83.
